Zobrazeno 1 - 10
of 281
pro vyhledávání: '"M Harrigan"'
Publikováno v:
Current Oncology, Vol 29, Iss 9, Pp 6419-6432 (2022)
Cancer-associated venous thromboembolism is a devastating complication of cancer and is associated with significant morbidity and mortality. The cornerstone of cancer-associated venous thromboembolism treatment is anticoagulation, and in recent years
Externí odkaz:
https://doaj.org/article/773eca9aa66a4a0ba6370ee75ef33fd5
Autor:
Michael Berk, Mohammadreza Mohebbi, Olivia M. Dean, Sue M. Cotton, Andrew M. Chanen, Seetal Dodd, Aswin Ratheesh, G. Paul Amminger, Mark Phelan, Amber Weller, Andrew Mackinnon, Francesco Giorlando, Shelley Baird, Lisa Incerti, Rachel E. Brodie, Natalie O. Ferguson, Simon Rice, Miriam R. Schäfer, Edward Mullen, Sarah Hetrick, Melissa Kerr, Susy M. Harrigan, Amelia L. Quinn, Catherine Mazza, Patrick McGorry, Christopher G. Davey
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background Inflammation contributes to the pathophysiology of major depressive disorder (MDD), and anti-inflammatory strategies might therefore have therapeutic potential. This trial aimed to determine whether adjunctive aspirin or rosuvasta
Externí odkaz:
https://doaj.org/article/e324650ad0254ef1909b710205791da0
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Rationale: Alemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse events have been associated with alemtuzumab, including renal-limited anti-glomerular baseme
Externí odkaz:
https://doaj.org/article/c8976202fe4e49999d85e051a78fb074
Autor:
B. Chiaro, C. Neill, A. Bohrdt, M. Filippone, F. Arute, K. Arya, R. Babbush, D. Bacon, J. Bardin, R. Barends, S. Boixo, D. Buell, B. Burkett, Y. Chen, Z. Chen, R. Collins, A. Dunsworth, E. Farhi, A. Fowler, B. Foxen, C. Gidney, M. Giustina, M. Harrigan, T. Huang, S. Isakov, E. Jeffrey, Z. Jiang, D. Kafri, K. Kechedzhi, J. Kelly, P. Klimov, A. Korotkov, F. Kostritsa, D. Landhuis, E. Lucero, J. McClean, X. Mi, A. Megrant, M. Mohseni, J. Mutus, M. McEwen, O. Naaman, M. Neeley, M. Niu, A. Petukhov, C. Quintana, N. Rubin, D. Sank, K. Satzinger, T. White, Z. Yao, P. Yeh, A. Zalcman, V. Smelyanskiy, H. Neven, S. Gopalakrishnan, D. Abanin, M. Knap, J. Martinis, P. Roushan
Publikováno v:
Physical Review Research, Vol 4, Iss 1, p 013148 (2022)
The interplay of interactions and strong disorder can lead to an exotic quantum many-body localized (MBL) phase of matter. Beyond the absence of transport, the MBL phase has distinctive signatures, such as slow dephasing and logarithmic entanglement
Externí odkaz:
https://doaj.org/article/9730720d85f1446e9d010b56c4aee4a2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gregory Piazza, Shelley Hurwitz, Lindsay M. Harrigan, Kathryn L. Jenkins, Benjamin Hohlfelder, John Fanikos, Samuel Z. Goldhaber
Publikováno v:
TH Open, Vol 02, Iss 01, Pp e33-e38 (2018)
Abstract Atrial fibrillation (AF) is associated with an increased rate of mortality, heart failure, and stroke. We conducted an observational study to assess the relationship between anticoagulation and adverse clinical outcomes in hospitalized patie
Externí odkaz:
https://doaj.org/article/6a7271efba494c35a7e72545901095d1
Autor:
Amye M. Harrigan, Amy M. Trottier
Acute myeloid leukemia with germline CEBPA mutation is a subtype of acute myeloid leukemia that is associated with a favorable prognosis. Most of the reported cases of acute myeloid leukemia with CEBPA germline variants involve a germline variant in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57b20fd8d1ba35b2e4f860803ef314b
https://doi.org/10.21203/rs.3.rs-2167397/v1
https://doi.org/10.21203/rs.3.rs-2167397/v1
Publikováno v:
Journal of Hematology
TERC variant telomere biology disorders (TBDs) are a rare, heterogenous group of disorders that arise from germline variants in TERC , a gene that encodes for the RNA component of telomerase. Variants in TERC lead to accelerated telomere attrition an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c753ca4e742766389df1bf02dcadad7
http://europepmc.org/articles/PMC8256918
http://europepmc.org/articles/PMC8256918
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease
Rationale: Alemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse events have been associated with alemtuzumab, including renal-limited anti-glomerular baseme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2852e1c0feb8cf1035d4cac9952267f
https://doaj.org/article/c8976202fe4e49999d85e051a78fb074
https://doaj.org/article/c8976202fe4e49999d85e051a78fb074